Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute, Québec, Canada.
Genetic Dyslipidemias Clinic of the Montreal Clinical Research Institute, Québec, Canada.
Atherosclerosis. 2021 Jul;329:9-13. doi: 10.1016/j.atherosclerosis.2021.06.006. Epub 2021 Jun 11.
Familial hypercholesterolemia (FH) is a genetic disease, with an autosomal codominant inheritance, predisposing to premature atherosclerotic cardiovascular disease (ASCVD). Paternal or maternal inheritance of the FH-causing mutation may affect the FH phenotype in offspring, but the effect of the genetic transmission on cardiovascular disease risk remains to be established. The aim of the present study is to compare the incidence of cardiovascular events between patients with maternal vs paternal inheritance of familial hypercholesterolemia.
We prospectively studied 725 genetically-confirmed FH patients (33,805 person-years), including 268 with maternal inheritance and 321 with paternal inheritance of the mutation. ASCVD was defined as angina, myocardial infarction, coronary angioplasty, coronary bypass surgery, claudication, peripheral angioplasty, peripheral arterial surgery, transient ischemic attack, stroke, carotid endarterectomy and CV death. Cox-proportional hazard models and Kaplan-Meier analysis were used to compare the two groups.
Before 50 years of age, paternal inheritance of FH was associated with a 1.5-fold increased risk for ASCVD, as compared to maternal inheritance (HR 1.59, 95% CI 1.11-2.28, p = 0.01). This association remained significant after adjusting for confounding factors (HR 1.49, 95% CI 1.00-2.23, p = 0.05). The age of first ASCVD event was also significantly lower in the paternal inheritance group (42 years) than in the maternal inheritance group (46 years), p = 0.02.
This study suggests that paternal inheritance of the FH-causing mutation was associated with an earlier cardiovascular event onset compared to maternal inheritance. The mechanisms behind these findings remain to be established.
家族性高胆固醇血症(FH)是一种常染色体显性遗传疾病,易导致早发性动脉粥样硬化性心血管疾病(ASCVD)。FH 致病突变的父系或母系遗传可能会影响后代的 FH 表型,但遗传传递对心血管疾病风险的影响仍有待确定。本研究旨在比较母系和父系 FH 遗传患者的心血管事件发生率。
我们前瞻性研究了 725 例经基因证实的 FH 患者(33805 人年),其中 268 例为母系遗传,321 例为父系遗传。ASCVD 定义为心绞痛、心肌梗死、冠状动脉成形术、冠状动脉旁路移植术、跛行、外周血管成形术、外周动脉手术、短暂性脑缺血发作、中风、颈动脉内膜切除术和心血管死亡。使用 Cox 比例风险模型和 Kaplan-Meier 分析比较两组。
在 50 岁之前,与母系遗传相比,FH 的父系遗传与 ASCVD 风险增加 1.5 倍相关(HR 1.59,95%CI 1.11-2.28,p=0.01)。调整混杂因素后,这种相关性仍然显著(HR 1.49,95%CI 1.00-2.23,p=0.05)。父系遗传组首次 ASCVD 事件的年龄也明显低于母系遗传组(42 岁 vs 46 岁,p=0.02)。
本研究表明,与母系遗传相比,FH 致病突变的父系遗传与心血管事件发生较早相关。这些发现背后的机制仍有待确定。